General MedicationsInjectionGeneric
TRIFLUOPERAZINE HCL
TRIFLUOPERAZINE HYDROCHLORIDE
Standard Dose
EQ 2MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview TRIFLUOPERAZINE HCL is listed in Drugs@FDA under application 089893 (ANDA).
Marketing status: Discontinued Active ingredient TRIFLUOPERAZINE HYDROCHLORIDE Form and strength Injectable; Injection - EQ 2MG BASE/ML Sponsor QUAD PHARMS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview TRIFLUOPERAZINE HCL is listed in Drugs@FDA under application 089893 (ANDA). Marketing status: Discontinued Active ingredient TRIFLUOPERAZINE HYDROCHLORIDE Form and strength Injectable; Injection - EQ 2MG BASE/ML Sponsor QUAD PHARMS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.